This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Mabswitch Inc

Profile

MabSwitch utilizes a proprietary universal allosteric-linker and switch module for antibodies UNASMA technology to engineer control switches to regulate the activity and improve the efficacy of next-generation antibody-based immunotherapies. An awardee of a QuickFire Challenge sponsored by J&J and winner of two Biolabs Golden Tickets supported by Abbvie and BMS, Mabswitch recently was awarded a Phase 1 SBIR grant by the NIH to advance it's regulatable CAR-T cell therapy (SaefCAR) program.